Long term efficacy of a 2-year MRI treat-to-target strategy on disease activity, MRI inflammation and physical function in rheumatoid arthritis patients in clinical remission: five year follow-up of the IMAGINE RA-cohort

Signe Kaas Møller-Bisgaard; Kim Hørslev-Pedersen; Daniel Erik Glinatsi; B Ejbjerg; Merete Lund Hetland; Jakob Møllenbach Møller; Robin Christensen; S M Nielsen; Mikael Boesen; K Stengaard-Pedersen; O Madsen; B. Jensen; Jan Alexander Villadsen; EM Hauge; Oliver Hendricks; H.M. Lindegaard; Niels Steen Krogh; Anne Grethe Jurik; H Thomsen; Mikkel Østergaard

Long term efficacy of a 2-year MRI treat-to-target strategy on disease activity, MRI inflammation and physical function in rheumatoid arthritis patients in clinical remission: five year follow-up of the IMAGINE RA-cohort

Signe Kaas Møller-Bisgaard, Kim Hørslev-Pedersen, Daniel Erik Glinatsi, B Ejbjerg, Merete Lund Hetland, Jakob Møllenbach Møller, Robin Christensen, S M Nielsen, Mikael Boesen, K Stengaard-Pedersen, O Madsen, B. Jensen, Jan Alexander Villadsen, EM Hauge, Oliver Hendricks, H.M. Lindegaard, Niels Steen Krogh, Anne Grethe Jurik, H Thomsen, Mikkel Østergaard

Abstract

Background: Targeting MRI remission in rheumatoid arthritis (RA) patients in clinical remission may improve long term clinical, functional and MRI outcomes.

Original language	English
Publication date	2022
Publication status	Published - 2022
Event	EULAR 2022 - Copenhagen Duration: 1 Jun 2022 → 4 Jun 2022

Conference

Conference	EULAR 2022
City	Copenhagen
Period	01/06/2022 → 04/06/2022

Fingerprint

Dive into the research topics of 'Long term efficacy of a 2-year MRI treat-to-target strategy on disease activity, MRI inflammation and physical function in rheumatoid arthritis patients in clinical remission: five year follow-up of the IMAGINE RA-cohort'. Together they form a unique fingerprint.

Cite this

Møller-Bisgaard, S. K., Hørslev-Pedersen, K., Glinatsi, D. E., Ejbjerg, B., Hetland, M. L., Møller, J. M., Christensen, R., Nielsen, S. M., Boesen, M., Stengaard-Pedersen, K., Madsen, O., Jensen, B., Villadsen, J. A., Hauge, EM., Hendricks, O., Lindegaard, H. M., Krogh, N. S., Jurik, A. G., Thomsen, H., & Østergaard, M. (2022). Long term efficacy of a 2-year MRI treat-to-target strategy on disease activity, MRI inflammation and physical function in rheumatoid arthritis patients in clinical remission: five year follow-up of the IMAGINE RA-cohort. Annals of the Rheumatic Diseases 81 Suppl 1: 539. Abstract from EULAR 2022, Copenhagen.

Long term efficacy of a 2-year MRI treat-to-target strategy on disease activity, MRI inflammation and physical function in rheumatoid arthritis patients in clinical remission: five year follow-up of the IMAGINE RA-cohort. / Møller-Bisgaard, Signe Kaas; Hørslev-Pedersen, Kim; Glinatsi, Daniel Erik et al.
2022. Annals of the Rheumatic Diseases 81 Suppl 1: 539 Abstract from EULAR 2022, Copenhagen.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Møller-Bisgaard, SK, Hørslev-Pedersen, K, Glinatsi, DE, Ejbjerg, B, Hetland, ML , Møller, JM, Christensen, R, Nielsen, SM, Boesen, M, Stengaard-Pedersen, K, Madsen, O, Jensen, B, Villadsen, JA, Hauge, EM, Hendricks, O, Lindegaard, HM, Krogh, NS, Jurik, AG, Thomsen, H & Østergaard, M 2022, 'Long term efficacy of a 2-year MRI treat-to-target strategy on disease activity, MRI inflammation and physical function in rheumatoid arthritis patients in clinical remission: five year follow-up of the IMAGINE RA-cohort', EULAR 2022, Copenhagen, 01/06/2022 - 04/06/2022 pp. Annals of the Rheumatic Diseases 81 Suppl 1: 539.

@conference{9d0de5280eb841cb88cc7597c097e40e,

title = "Long term efficacy of a 2-year MRI treat-to-target strategy on disease activity, MRI inflammation and physical function in rheumatoid arthritis patients in clinical remission: five year follow-up of the IMAGINE RA-cohort",

abstract = "Background: Targeting MRI remission in rheumatoid arthritis (RA) patients in clinical remission may improve long term clinical, functional and MRI outcomes.",

author = "M{\o}ller-Bisgaard, {Signe Kaas} and Kim H{\o}rslev-Pedersen and Glinatsi, {Daniel Erik} and B Ejbjerg and Hetland, {Merete Lund} and M{\o}ller, {Jakob M{\o}llenbach} and Robin Christensen and Nielsen, {S M} and Mikael Boesen and K Stengaard-Pedersen and O Madsen and B. Jensen and Villadsen, {Jan Alexander} and EM Hauge and Oliver Hendricks and H.M. Lindegaard and Krogh, {Niels Steen} and Jurik, {Anne Grethe} and H Thomsen and Mikkel {\O}stergaard",

note = "COPECARE; EULAR 2022 ; Conference date: 01-06-2022 Through 04-06-2022",

year = "2022",

language = "English",

pages = "Annals of the Rheumatic Diseases 81 Suppl 1: 539",

}

TY - ABST

T1 - Long term efficacy of a 2-year MRI treat-to-target strategy on disease activity, MRI inflammation and physical function in rheumatoid arthritis patients in clinical remission: five year follow-up of the IMAGINE RA-cohort

AU - Møller-Bisgaard, Signe Kaas

AU - Hørslev-Pedersen, Kim

AU - Glinatsi, Daniel Erik

AU - Ejbjerg, B

AU - Hetland, Merete Lund

AU - Møller, Jakob Møllenbach

AU - Christensen, Robin

AU - Nielsen, S M

AU - Boesen, Mikael

AU - Stengaard-Pedersen, K

AU - Madsen, O

AU - Jensen, B.

AU - Villadsen, Jan Alexander

AU - Hauge, EM

AU - Hendricks, Oliver

AU - Lindegaard, H.M.

AU - Krogh, Niels Steen

AU - Jurik, Anne Grethe

AU - Thomsen, H

AU - Østergaard, Mikkel

N1 - COPECARE

PY - 2022

Y1 - 2022

N2 - Background: Targeting MRI remission in rheumatoid arthritis (RA) patients in clinical remission may improve long term clinical, functional and MRI outcomes.

AB - Background: Targeting MRI remission in rheumatoid arthritis (RA) patients in clinical remission may improve long term clinical, functional and MRI outcomes.

M3 - Conference abstract for conference

SP - Annals of the Rheumatic Diseases 81 Suppl 1: 539

T2 - EULAR 2022

Y2 - 1 June 2022 through 4 June 2022

ER -